These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15760073)

  • 1. A method to determine the incorporation capacity of camptothecin in liposomes.
    Saetern AM; Flaten GE; Brandl M
    AAPS PharmSciTech; 2004 Jun; 5(3):e40. PubMed ID: 15760073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial lipids stabilized camptothecin incorporated in liposomes.
    Maitani Y; Katayama S; Kawano K; Hayama A; Toma K
    Biol Pharm Bull; 2008 May; 31(5):990-3. PubMed ID: 18451532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution.
    Flaten GE; Chang TT; Phillips WT; Brandl M; Bao A; Goins B
    J Liposome Res; 2013 Mar; 23(1):70-81. PubMed ID: 23210622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camptothecin-catalyzed phospholipid hydrolysis in liposomes.
    Saetern AM; Skar M; Braaten A; Brandl M
    Int J Pharm; 2005 Jan; 288(1):73-80. PubMed ID: 15607259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin.
    Whitaker RD; Ingebrigtsen SG; Naderkhani E; Skar ML; Flaten GE
    J Liposome Res; 2013 Dec; 23(4):298-310. PubMed ID: 23763495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal solubilization of new 3-hydroxy-quinolinone derivatives with promising anticancer activity: a screening method to identify maximum incorporation capacity.
    di Cagno M; Styskala J; Hlaváč J; Brandl M; Bauer-Brandl A; Skalko-Basnet N
    J Liposome Res; 2011 Dec; 21(4):272-8. PubMed ID: 21323606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes.
    Campbell RB; Balasubramanian SV; Straubinger RM
    J Pharm Sci; 2001 Aug; 90(8):1091-105. PubMed ID: 11536214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
    Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
    Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions.
    Lundberg BB
    Anticancer Drug Des; 1998 Jul; 13(5):453-61. PubMed ID: 9702210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition-A formulation screening study.
    Holsæter AM; Wizgird K; Karlsen I; Hemmingsen JF; Brandl M; Škalko-Basnet N
    Eur J Pharm Sci; 2022 Oct; 177():106267. PubMed ID: 35872073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts.
    Daoud SS; Fetouh MI; Giovanella BC
    Anticancer Drugs; 1995 Feb; 6(1):83-93. PubMed ID: 7756688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization and skin permeation of liposome formulations containing clindamycin phosphate.
    Shanmugam S; Song CK; Nagayya-Sriraman S; Baskaran R; Yong CS; Choi HG; Kim DD; Woo JS; Yoo BK
    Arch Pharm Res; 2009 Jul; 32(7):1067-75. PubMed ID: 19641889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camptothecin in sterically stabilized phospholipid nano-micelles: a novel solvent pH change solubilization method.
    Koo OM; Rubinstein I; Onyuksel H
    J Nanosci Nanotechnol; 2006; 6(9-10):2996-3000. PubMed ID: 17048510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.
    Watanabe M; Kawano K; Toma K; Hattori Y; Maitani Y
    J Control Release; 2008 May; 127(3):231-8. PubMed ID: 18384903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimeric camptothecin derived phospholipid assembled liposomes with high drug loading for cancer therapy.
    Fang S; Hou Y; Ling L; Wang D; Ismail M; Du Y; Zhang Y; Yao C; Li X
    Colloids Surf B Biointerfaces; 2018 Jun; 166():235-244. PubMed ID: 29604567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile synthesis of camptothecin intercalated layered double hydroxide nanohybrids via a coassembly route.
    Wu X; Li H; Song S; Zhang R; Hou W
    Int J Pharm; 2013 Sep; 454(1):453-61. PubMed ID: 23820133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers.
    Barreiro-Iglesias R; Bromberg L; Temchenko M; Hatton TA; Concheiro A; Alvarez-Lorenzo C
    J Control Release; 2004 Jul; 97(3):537-49. PubMed ID: 15212885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying.
    Hinrichs WL; Manceñido FA; Sanders NN; Braeckmans K; De Smedt SC; Demeester J; Frijlink HW
    Int J Pharm; 2006 Mar; 311(1-2):237-44. PubMed ID: 16442758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.